TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Probiotics and Effects on Illness-Related Symptoms for Pre-School Age Children
Brief Summary: The aim of the present prospective study is to investigate whether the consumption of certain probiotic strains over a six-month winter/spring season would be able to affect the incidence and duration of upper respiratory tract infections, in otherwise healthy children as well as determining whether a combination of two strains would perform differently from a single strain version.


Options:
A: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Active 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Lactobacillus acidophilus NCFM | Arm Label: Active 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Combination of Lactobacillus acidophilus and Bifidobacterium lactis | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus acidophilus NCFM; Assigned to Arm(s): Active 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Combination of Lactobacillus acidophilus and Bifidobacterium lactis; Assigned to Arm(s): Active 2
B: Arm Label: Yogurt smoothie without probiotic.; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Yogurt smoothie without probiotic | Arm Label: Probiotic added post fermentation.; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Yogurt smoothie with probiotic added post fermentation | Arm Label: Probiotic added pre-fermentation.; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Yogurt smoothie with probiotic added pre-fermentation | Arm Label: A capsule containing the probiotic.; Type: EXPERIMENTAL; Interventions: Dietary Supplement: A capsule containing the probiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Yogurt smoothie without probiotic; Assigned to Arm(s): Yogurt smoothie without probiotic. | Intervention Type: DIETARY_SUPPLEMENT; Name: Yogurt smoothie with probiotic added post fermentation; Assigned to Arm(s): Probiotic added post fermentation. | Intervention Type: DIETARY_SUPPLEMENT; Name: Yogurt smoothie with probiotic added pre-fermentation; Assigned to Arm(s): Probiotic added pre-fermentation. | Intervention Type: DIETARY_SUPPLEMENT; Name: A capsule containing the probiotic; Assigned to Arm(s): A capsule containing the probiotic.
C: Arm Label: Lreuteri; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lreuteri | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Lreuteri; Assigned to Arm(s): Lreuteri | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Probiotics; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Probiotic | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Double Blind Controlled Trial on the Effect of Treatment in Children With Obstructive Sleep Apnea Syndrome.
Brief Summary: Oral therapy with montelukast may lead to improved polysomnographic findings in children with mild to moderate OSAS with and without allergic rhinitis who a priori require T\&A for OSAS.

- A significant proportion of the children with OSAS treated with montelukast will show reduced severity of OSAS, and this will obviate the need for surgical T\&A.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Montelukast | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Montelukast; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Early AT Surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Adenotonsillectomy (AT) - removal of adenoids and tonsils | Arm Label: Watchful Waiting; Type: OTHER; Interventions: Other: Watchful Waiting | Intervention Type: PROCEDURE; Name: Adenotonsillectomy (AT) - removal of adenoids and tonsils; Assigned to Arm(s): Early AT Surgery | Intervention Type: OTHER; Name: Watchful Waiting; Assigned to Arm(s): Watchful Waiting
C: Arm Label: Aerosal; Type: EXPERIMENTAL; Interventions: Device: Halotherapy | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Device: Placebo | Intervention Type: DEVICE; Name: Halotherapy; Assigned to Arm(s): Aerosal | Intervention Type: DEVICE; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Budesonide; Type: EXPERIMENTAL; Interventions: Drug: Budesonide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Budesonide; Assigned to Arm(s): Budesonide | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Treating Migraine With Acupuncture
Brief Summary: The purpose of the study is to testify whether acupuncture is effective for migraine, and provide evidence for the hypothesis that"Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."


Options:
A: Intervention Type: DEVICE; Name: Acupuncture; Assigned to Arm(s): N/A
B: Arm Label: group 1; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 3; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 4; Type: SHAM_COMPARATOR; Interventions: Other: acupuncture | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): Group 2, group 1, group 3, group 4
C: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Procedure: acupuncture | Arm Label: topiramate; Type: ACTIVE_COMPARATOR; Interventions: Drug: topiramate | Intervention Type: PROCEDURE; Name: acupuncture; Assigned to Arm(s): acupuncture | Intervention Type: DRUG; Name: topiramate; Assigned to Arm(s): topiramate
D: Arm Label: acupoint-meridian group; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: sham-acupoint group; Type: OTHER; Interventions: Other: acupuncture | Arm Label: waiting list; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): acupoint-meridian group, sham-acupoint group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Treating Migraine With Acupuncture
Brief Summary: The purpose of the study is to testify whether acupuncture is effective for migraine, and provide evidence for the hypothesis that"Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."


Options:
A: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Other: acupuncture, injection | Arm Label: injections of diclofenac; Type: ACTIVE_COMPARATOR; Interventions: Other: acupuncture, injection | Intervention Type: OTHER; Name: acupuncture, injection; Assigned to Arm(s): acupuncture, injections of diclofenac
B: Arm Label: 1; Type: SHAM_COMPARATOR; Interventions: Device: Acupuncture | Intervention Type: DEVICE; Name: Acupuncture; Assigned to Arm(s): 1
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: B; Type: EXPERIMENTAL; Interventions: Other: acupuncture and moxibustion | Arm Label: C; Type: EXPERIMENTAL; Interventions: Other: electroacupuncture | Arm Label: D; Type: EXPERIMENTAL; Interventions: Other: acupuncture along yangming tendons | Arm Label: E; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): A | Intervention Type: OTHER; Name: acupuncture and moxibustion; Assigned to Arm(s): B | Intervention Type: OTHER; Name: electroacupuncture; Assigned to Arm(s): C | Intervention Type: OTHER; Name: acupuncture along yangming tendons; Assigned to Arm(s): D | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): E
D: Arm Label: group 1; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 3; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 4; Type: SHAM_COMPARATOR; Interventions: Other: acupuncture | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): Group 2, group 1, group 3, group 4

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Acupuncture for Functional Dyspepsia
Brief Summary: The purpose of the study is to testify the efficacy of treating functional dyspepsia with acupuncture, and provide evidence for the hypothesis that "Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."


Options:
A: Arm Label: group 1; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 2; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 3; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 4; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 5; Type: SHAM_COMPARATOR; Interventions: Other: acupuncture | Arm Label: group 6; Type: ACTIVE_COMPARATOR; Interventions: Drug: Itopride | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): group 1, group 2, group 3, group 4, group 5 | Intervention Type: DRUG; Name: Itopride; Assigned to Arm(s): group 6
B: Arm Label: group 1; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 3; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 4; Type: SHAM_COMPARATOR; Interventions: Other: acupuncture | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): Group 2, group 1, group 3, group 4
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: B; Type: EXPERIMENTAL; Interventions: Other: acupuncture and moxibustion | Arm Label: C; Type: EXPERIMENTAL; Interventions: Other: electroacupuncture | Arm Label: D; Type: EXPERIMENTAL; Interventions: Other: acupuncture along yangming tendons | Arm Label: E; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): A | Intervention Type: OTHER; Name: acupuncture and moxibustion; Assigned to Arm(s): B | Intervention Type: OTHER; Name: electroacupuncture; Assigned to Arm(s): C | Intervention Type: OTHER; Name: acupuncture along yangming tendons; Assigned to Arm(s): D | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): E
D: Arm Label: 1; Type: SHAM_COMPARATOR; Interventions: Device: Acupuncture | Intervention Type: DEVICE; Name: Acupuncture; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nifedipine Compared to Atosiban for Treating Preterm Labor. A Randomized Controlled Trial.
Brief Summary: The purpose of this study is to investigate the efficacy and the safety of nifedipine compared to atosiban for treating preterm labor.


Options:
A: Arm Label: Atosiban; Type: EXPERIMENTAL; Interventions: Drug: Atosiban | Arm Label: Nifedipine; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine
B: Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Magnesium sulfate; Assigned to Arm(s): N/A
C: Arm Label: Nifedipine; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine | Arm Label: Atosiban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atosiban | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Atosiban | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Intravenous Local Anesthetic on Bowel Function After Colectomy
Brief Summary: Epidural local anesthetics are the gold standard for shortening duration of bowel dysfunction after bowel surgery. Previous studies suggest that their effect may be in part a result of actions of the local anesthetic outside the epidural space. If local anesthetics could be administered intravenously instead, this might be a safer, easier and less expensive approach. Therefore, this trial will compare the effect on bowel function recovery of intravenous local anesthetics with those administered epidurally.


Options:
A: Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: lidocaine | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: bupivacaine with hydromorphone | Intervention Type: DRUG; Name: bupivacaine with hydromorphone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: lidocaine; Assigned to Arm(s): 2
B: Arm Label: Lidocaine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lidocaine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): Lidocaine
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Lidocaine; Type: EXPERIMENTAL; Interventions: Drug: Lidocaine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): Lidocaine
D: Arm Label: Intravenous lidocaine injection group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous lidocaine injection | Arm Label: Placebo control group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Intravenous normal saline injection | Intervention Type: DRUG; Name: Intravenous lidocaine injection; Assigned to Arm(s): Intravenous lidocaine injection group | Intervention Type: DRUG; Name: Intravenous normal saline injection; Assigned to Arm(s): Placebo control group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blind, Placebo Controlled, Parallel Group, Dose Ranging Study Evaluating the Efficacy and Safety of GW642444M Administered Once Daily Compared With Placebo for 28 Days in Adolescent and Adult Subjects With Persistent Asthma
Brief Summary: This study is designed to determine if the investigational drug is effective and safe in individuals with asthma


Options:
A: Arm Label: Arm 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: GW685698X | Intervention Type: DRUG; Name: GW685698X; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Arm 1
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: GW685698X 200mcg,GW685698X 200mcg and 400mcg | Intervention Type: DRUG; Name: GW685698X 200mcg,GW685698X 200mcg and 400mcg; Assigned to Arm(s): Arm 1
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: GW642444M; Type: EXPERIMENTAL; Interventions: Drug: GW642444M | Intervention Type: DRUG; Name: GW642444M; Assigned to Arm(s): GW642444M | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: inhaled corticosteroid(ICS)/long acting bronchodilator (LABA); Type: ACTIVE_COMPARATOR; Interventions: Drug: FF/Vilanterol (VI; GW642444M) | Arm Label: ICS; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone Furoate | Intervention Type: DRUG; Name: Fluticasone Furoate; Assigned to Arm(s): ICS | Intervention Type: DRUG; Name: FF/Vilanterol (VI; GW642444M); Assigned to Arm(s): inhaled corticosteroid(ICS)/long acting bronchodilator (LABA) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of Biopsychosocial Education on Quality of Life and Disability of Individuals Suffering From Chronic Low Back Pain
Brief Summary: The purpose of this study is to examine whether the biopsychosocial educational program could improve patients' health-related quality of life at 3-6-12-18-24-30 and 36 - month follow up.


Options:
A: Arm Label: Lifestyles A; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyles A | Arm Label: Lifestyle B; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyles B | Arm Label: Lifestyles C; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lifestyles C | Intervention Type: BEHAVIORAL; Name: Lifestyles A; Assigned to Arm(s): Lifestyles A | Intervention Type: BEHAVIORAL; Name: Lifestyles B; Assigned to Arm(s): Lifestyle B | Intervention Type: BEHAVIORAL; Name: Lifestyles C; Assigned to Arm(s): Lifestyles C
B: Arm Label: Back school; Type: EXPERIMENTAL; Interventions: Behavioral: back school | Arm Label: back school; Type: EXPERIMENTAL; Interventions: Behavioral: back school | Intervention Type: BEHAVIORAL; Name: back school; Assigned to Arm(s): Back school, back school
C: Arm Label: ACT; Type: EXPERIMENTAL; Interventions: Behavioral: ACT | Arm Label: Physical activity; Type: EXPERIMENTAL; Interventions: Other: Physical activity | Arm Label: Experience based discussion group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ACT; Assigned to Arm(s): ACT | Intervention Type: OTHER; Name: Physical activity; Assigned to Arm(s): Physical activity
D: Arm Label: CBT-I; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I) | Arm Label: CBT-P; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for Pain (CBT-P) | Arm Label: Waitlist Control (WLC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for Insomnia (CBT-I); Assigned to Arm(s): CBT-I | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for Pain (CBT-P); Assigned to Arm(s): CBT-P

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of Biopsychosocial Education on Quality of Life and Disability of Individuals Suffering From Chronic Low Back Pain
Brief Summary: The purpose of this study is to examine whether the biopsychosocial educational program could improve patients' health-related quality of life at 3-6-12-18-24-30 and 36 - month follow up.


Options:
A: Arm Label: Back school; Type: EXPERIMENTAL; Interventions: Behavioral: back school | Arm Label: back school; Type: EXPERIMENTAL; Interventions: Behavioral: back school | Intervention Type: BEHAVIORAL; Name: back school; Assigned to Arm(s): Back school, back school
B: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Manual / Manipulative Therapy (M/MT) | Intervention Type: PROCEDURE; Name: Manual / Manipulative Therapy (M/MT); Assigned to Arm(s): 2
C: Arm Label: Tanezumab 20 mg IV; Type: EXPERIMENTAL; Interventions: Biological: Tanezumab 20 mg IV, Drug: Placebo for naproxen | Arm Label: Tanezumab 10 mg IV; Type: EXPERIMENTAL; Interventions: Biological: Tanezumab 10 mg IV, Drug: Placebo for naproxen | Arm Label: Tanezumab 5 mg IV; Type: EXPERIMENTAL; Interventions: Biological: Tanezumab 5 mg IV, Drug: Placebo for naproxen | Arm Label: Naproxen; Type: ACTIVE_COMPARATOR; Interventions: Biological: Placebo for tanezumab, Drug: Naproxen | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo for tanezumab, Drug: Placebo for naproxen | Intervention Type: BIOLOGICAL; Name: Tanezumab 20 mg IV; Assigned to Arm(s): Tanezumab 20 mg IV | Intervention Type: DRUG; Name: Placebo for naproxen; Assigned to Arm(s): Tanezumab 20 mg IV | Intervention Type: BIOLOGICAL; Name: Tanezumab 10 mg IV; Assigned to Arm(s): Tanezumab 10 mg IV | Intervention Type: DRUG; Name: Placebo for naproxen; Assigned to Arm(s): Tanezumab 10 mg IV | Intervention Type: BIOLOGICAL; Name: Tanezumab 5 mg IV; Assigned to Arm(s): Tanezumab 5 mg IV | Intervention Type: DRUG; Name: Placebo for naproxen; Assigned to Arm(s): Tanezumab 5 mg IV | Intervention Type: BIOLOGICAL; Name: Placebo for tanezumab; Assigned to Arm(s): Naproxen | Intervention Type: DRUG; Name: Naproxen; Assigned to Arm(s): Naproxen | Intervention Type: BIOLOGICAL; Name: Placebo for tanezumab; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo for naproxen; Assigned to Arm(s): Placebo
D: Arm Label: Tramadol Hydrochloride (HCl)/acetaminophen; Type: EXPERIMENTAL; Interventions: Drug: Tramadol HCl/acetaminophen Extended Release | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tramadol HCl/acetaminophen Extended Release; Assigned to Arm(s): Tramadol Hydrochloride (HCl)/acetaminophen | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Tramadol HCl/acetaminophen Extended Release; Assigned to Arm(s): Tramadol Hydrochloride (HCl)/acetaminophen | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Phase III 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab for the First-line Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Locally Recurrent or Metastatic Breast Cancer
Brief Summary: First-line treatment of patients with locally recurrent or metastatic, HER2-negative breast cancer who have not received prior chemotherapy for locally recurrent or metastatic disease.


Options:
A: Arm Label: Standard Chemotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard Treatment | Arm Label: Capecitabine; Type: EXPERIMENTAL; Interventions: Drug: capecitabine | Intervention Type: DRUG; Name: Standard Treatment; Assigned to Arm(s): Standard Chemotherapy | Intervention Type: DRUG; Name: capecitabine; Assigned to Arm(s): Capecitabine
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chemotherapy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: bevacizumab [Avastin], Drug: Chemotherapy | Intervention Type: DRUG; Name: bevacizumab [Avastin]; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Chemotherapy; Assigned to Arm(s): 1, 2
C: Arm Label: A Bev+Pac; Type: ACTIVE_COMPARATOR; Interventions: Biological: Bevacizumab and Paclitaxel | Arm Label: B Bev+Cap; Type: ACTIVE_COMPARATOR; Interventions: Biological: Bevacizumab and Capecitabine | Intervention Type: BIOLOGICAL; Name: Bevacizumab and Paclitaxel; Assigned to Arm(s): A Bev+Pac | Intervention Type: BIOLOGICAL; Name: Bevacizumab and Capecitabine; Assigned to Arm(s): B Bev+Cap
D: Arm Label: Arm A: bevacizumab and paclitaxel; Type: ACTIVE_COMPARATOR; Interventions: Biological: bevacizumab, Paclitaxel | Arm Label: Arm B: bevacizumab, cyclophosphamide and capecitabine; Type: ACTIVE_COMPARATOR; Interventions: Biological: Bevacizumab, Cyclophosphamide, Capecitabine | Intervention Type: BIOLOGICAL; Name: bevacizumab, Paclitaxel; Assigned to Arm(s): Arm A: bevacizumab and paclitaxel | Intervention Type: BIOLOGICAL; Name: Bevacizumab, Cyclophosphamide, Capecitabine; Assigned to Arm(s): Arm B: bevacizumab, cyclophosphamide and capecitabine

Answer: C